Chylous Ascites in a Patient on Peritoneal Dialysis with Recurrent T Cell Post-transplant Lymphoproliferative Disorder after Transplantation from a Living Unrelated Kidney Donor

Introduction: Chylous ascites is a rare manifestation of abdominal lymphatic system disruption; ascites fluid appears cloudy and is characterized by elevated triglyceride levels. Few reports exist of chylous ascites in patients on peritoneal dialysis (PD) or in patients following solid organ transplantation. We report a case of chylous ascites in a patient on peritoneal dialysis with recurrent post-transplant lymphoproliferative disorder (PTLD) following a living unrelated kidney transplant (LUKT). Case Description: A 54 year old man with ESKD due to IgA nephropathy who received a LUKT in 2018 that was complicated by T-cell mediated rejection in 2022 leading to allograft failure and initiation of peritoneal dialysis (PD) in 2023 presented with cloudy PD fluid and mild abdominal discomfort. Additional history included T-Cell lymphoma characterized as PTLD in 2021 treated to complete metabolic response. Both donor and recipient were EBV seropositive at the time of LUKT. Gross examination revealed cloudy PD fluid; initial PD fluid studies demonstrated 84 total nucleated cells per microliter with 1% neutrophils. PD fluid cultures and smears for acid-fast bacilli were both negative. Ascites fluid triglyceride level was 412 mg/dL (serum 133 mg/dL). A CT abdomen and pelvis demonstrated bulky lymphadenopathy and a PET-CT scan confirmed severe progression of lymphoma. A PD catheter was appropriately positioned. PD was limited by inability to tolerate therapeutic fill volumes and persistent chylous ascites. Hemodialysis was initiated. Following initiation of chemotherapy, the patient developed tumor lysis syndrome and eventually expired. Discussion: We report chylous ascites as the initial presentation of severe recurrent PTLD following LUKT. Cloudy PD fluid warrants immediate and thorough evaluation and may raise suspicion for PTLD in post-transplant patients. Large volumes of chylous ascites may impair continuation of PD.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.20244cf8ff9c
Primary Topic
Lymphatic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chylous Ascites in a Patient on Peritoneal Dialysis with Recurrent T Cell Post-transplant Lymphoproliferative Disorder after Transplantation from a Living Unrelated Kidney Donor

Rebecca Kurnik Seshasai, Vishnu S. Potluri, Christopher R. Showers
Journal of the American Society of Nephrology
Lymphatic Disorders and Treatments
article

Chylous Ascites in a Patient on Peritoneal Dialysis with Recurrent T Cell Post-transplant Lymphoproliferative Disorder after Transplantation from a Living Unrelated Kidney Donor

Rebecca Kurnik Seshasai, Vishnu S. Potluri, Christopher R. Showers
article en

Abstract

Introduction: Chylous ascites is a rare manifestation of abdominal lymphatic system disruption; ascites fluid appears cloudy and is characterized by elevated triglyceride levels. Few reports exist of chylous ascites in patients on peritoneal dialysis (PD) or in patients following solid organ transplantation. We report a case of chylous ascites in a patient on peritoneal dialysis with recurrent post-transplant lymphoproliferative disorder (PTLD) following a living unrelated kidney transplant (LUKT). Case Description: A 54 year old man with ESKD due to IgA nephropathy who received a LUKT in 2018 that was complicated by T-cell mediated rejection in 2022 leading to allograft failure and initiation of peritoneal dialysis (PD) in 2023 presented with cloudy PD fluid and mild abdominal discomfort. Additional history included T-Cell lymphoma characterized as PTLD in 2021 treated to complete metabolic response. Both donor and recipient were EBV seropositive at the time of LUKT. Gross examination revealed cloudy PD fluid; initial PD fluid studies demonstrated 84 total nucleated cells per microliter with 1% neutrophils. PD fluid cultures and smears for acid-fast bacilli were both negative. Ascites fluid triglyceride level was 412 mg/dL (serum 133 mg/dL). A CT abdomen and pelvis demonstrated bulky lymphadenopathy and a PET-CT scan confirmed severe progression of lymphoma. A PD catheter was appropriately positioned. PD was limited by inability to tolerate therapeutic fill volumes and persistent chylous ascites. Hemodialysis was initiated. Following initiation of chemotherapy, the patient developed tumor lysis syndrome and eventually expired. Discussion: We report chylous ascites as the initial presentation of severe recurrent PTLD following LUKT. Cloudy PD fluid warrants immediate and thorough evaluation and may raise suspicion for PTLD in post-transplant patients. Large volumes of chylous ascites may impair continuation of PD.

Journal of the American Society of NephrologyVol. 35(10S)
Penn Center for AIDS Research (US), University of Pennsylvania Health System (US)
Openalex Percentile: Top 64%
Lymphatic Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.